acrolein has been researched along with Cardiovascular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Cicalo, C; Crowley, LN; Han, BK; Kim, JK; Kim, YJ; Le, BL; Lee, JH; Lennon, SL; Li, Y; Pan, JH | 1 |
| Liu, G; Lu, L; Mi, B; Wang, G; Xiong, Y; Zhou, J | 1 |
| Abplanalp, W; Becher, C; Bhatnagar, A; Chugh, A; Ciszewski, T; Conklin, DJ; DeFilippis, A; DeJarnett, N; Hamzeh, I; Higdon, D; McCracken, J; Myers, JA; O'Toole, TE; Prabhu, SD; Rai, SN; Ramos, KS; Riggs, DW; Srivastava, S; Tollerud, DJ; Wagner, S; Wyatt, B; Xie, Z; Yeager, R | 1 |
| Sindhu, KK | 1 |
| Coyle, JP; Harbison, RD; Henning, RJ; Johnson, GT | 1 |
| del Piano, M; La Palombara, P; Nicosia, R; Sessa, R | 1 |
| Gori, GB; Lynch, CJ | 1 |
| Cox, LR; Grossman, SL; Ramos, K | 1 |
4 review(s) available for acrolein and Cardiovascular Diseases
| Article | Year |
|---|---|
Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An update.
Topics: Acrolein; Aldehydes; Atherosclerosis; Cardiovascular Diseases; Environmental Pollutants; Hazardous Substances; Humans | 2022 |
The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases.
Topics: Acrolein; Cardiovascular Diseases; Drugs, Chinese Herbal; Glucose; Humans; Lipids | 2022 |
Uremic toxins: some thoughts on acrolein and spermine.
Topics: Acrolein; Cardiovascular Diseases; Comorbidity; Humans; Kidney Failure, Chronic; Oxidation-Reduction; Risk Factors; Spermine; Toxins, Biological; Uremia | 2016 |
Acrolein Can Cause Cardiovascular Disease: A Review.
Topics: Acrolein; Animals; Cardiovascular Diseases; Cigarette Smoking; Environmental Pollutants; Humans; Oxidative Stress | 2017 |
4 other study(ies) available for acrolein and Cardiovascular Diseases
| Article | Year |
|---|---|
Acrolein exposure is associated with increased cardiovascular disease risk.
Topics: Acetylcysteine; Acrolein; Adult; Aged; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Humans; Kentucky; Leukocytes; Linear Models; Male; Middle Aged; Platelet Activation; Smoking | 2014 |
[Pathology in firemen].
Topics: Acrolein; Adult; Burns, Inhalation; Carbon Dioxide; Carbon Monoxide; Cardiovascular Diseases; Cyanides; Fires; Humans; Hydrochloric Acid; Hydrogen Cyanide; Lung Diseases; Male; Middle Aged; Nitrogen Dioxide; Occupational Diseases; Smoke; Stress, Psychological | 1983 |
Toward less hazardous cigarettes. Current advances.
Topics: Acrolein; Cardiovascular Diseases; Dose-Response Relationship, Drug; Filtration; Humans; Hydrogen Cyanide; Lung Diseases; Neoplasms; Nitrogen Oxides; Risk; Smoking; Tars | 1978 |
Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Topics: Acrolein; Aldehydes; Allylamine; Amines; Animals; Benzylamine Oxidase; Cardiovascular Diseases; Cells, Cultured; Clorgyline; Ditiocarb; Endothelium, Vascular; Hydrogen Peroxide; L-Lactate Dehydrogenase; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Muscle, Smooth, Vascular; Pargyline; Rats; Rats, Inbred Strains; Semicarbazides | 1988 |